MDPI and ACS Style
Tomorowicz, Ł.; Żołnowska, B.; Szafrański, K.; Chojnacki, J.; Konopiński, R.; Grzybowska, E.A.; Sławiński, J.; Kawiak, A.
New 2-[(4-Amino-6-N-substituted-1,3,5-triazin-2-yl)methylthio]-N-(imidazolidin-2-ylidene)-4-chloro-5-methylbenzenesulfonamide Derivatives, Design, Synthesis and Anticancer Evaluation. Int. J. Mol. Sci. 2022, 23, 7178.
https://doi.org/10.3390/ijms23137178
AMA Style
Tomorowicz Ł, Żołnowska B, Szafrański K, Chojnacki J, Konopiński R, Grzybowska EA, Sławiński J, Kawiak A.
New 2-[(4-Amino-6-N-substituted-1,3,5-triazin-2-yl)methylthio]-N-(imidazolidin-2-ylidene)-4-chloro-5-methylbenzenesulfonamide Derivatives, Design, Synthesis and Anticancer Evaluation. International Journal of Molecular Sciences. 2022; 23(13):7178.
https://doi.org/10.3390/ijms23137178
Chicago/Turabian Style
Tomorowicz, Łukasz, Beata Żołnowska, Krzysztof Szafrański, Jarosław Chojnacki, Ryszard Konopiński, Ewa A. Grzybowska, Jarosław Sławiński, and Anna Kawiak.
2022. "New 2-[(4-Amino-6-N-substituted-1,3,5-triazin-2-yl)methylthio]-N-(imidazolidin-2-ylidene)-4-chloro-5-methylbenzenesulfonamide Derivatives, Design, Synthesis and Anticancer Evaluation" International Journal of Molecular Sciences 23, no. 13: 7178.
https://doi.org/10.3390/ijms23137178